Congrats to Big Pharma on Finding a New Way to Profit Off of HIV Prevention

Gilead, the company that makes Truvada, just got FDA approval for Descovy, another form of PrEP. It costs nearly £1,460 a month without insurance coverage.


How I Make My Mixed HIV Status Relationship Work

I'm HIV positive, but my partner is not. And though science has rendered that difference medically negligible, it's hard to shed decades of stigma overnight.


Meet the Man Helping Patients Bring Cheap HIV-Preventing Drugs to Canada

The Calgary nurse got the idea from ‘Dallas Buyers Club.’


How I Conquered My Fear and Fell in Love with an HIV+ Man

We spent three blissful years together—then a darkness took hold.


Stop Stigmatizing HIV-Positive Sex

The reaction to the sex life of a newly crowned Mr. Gay New Zealand is a reminder that our cultural baggage surrounding HIV is as heavy as ever.


This Doctor Is Fighting the AIDS Epidemic Spreading Among Black Men

Few populations are more at risk of contracting HIV than black men in Jackson, Mississippi. Dr. Leandro Mena runs a clinic there that fights back against this crisis.


10 Questions You Always Wanted to Ask a Person Who Is HIV Positive

"I don't think I need curing. I take one pill a day, and that being enough to stop me transmitting it, I feel that's all the cure I need."


Not Being on PrEP Is Making It Harder for Me to Get Laid

Thanks to PrEP, the pill that prevents HIV infection, guys like me who still use condoms are finding it a bit harder to bone.


We Spoke With the Club Owner Who Organises Sex Parties for HIV-positive Men

Richard Keldoulis has made it his mission to keep Amsterdam's gay scene alive.


Why Aren't Doctors Prescribing PrEP?

PrEP is a near-miraculous tool to fight HIV, but blind spots in our healthcare system and clinician biases may be inhibiting its use.


Why an AIDS Foundation's Crusade Against PrEP Is on the Wrong Side of History

The AIDS Healthcare Foundation has campaigned against a groundbreaking California measure mandating PrEP education—and puts marginalized groups at risk in doing so.


A Judge Just Ruled That the NHS Can Fund Anti-HIV Drugs, But the NHS Says It's Not Their Responsibility

The NHS had argued it's not responsible for providing PrEP, medication that can reduce the risk of being infected with HIV by up to 99 percent.